Endometriosis may surge women’s risk of heart attack by 35pc
New Delhi, Aug 29 (IANS) Women with endometriosis — a chronic gynaecological disease — are at a 35 per cent higher risk of severe heart attack, according to a study on Thursday. Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus, such as in the ovaries and fallopian
New Delhi, Aug 29 (IANS) Women with endometriosis — a chronic gynaecological disease — are at a 35 per cent higher risk of severe heart attack, according to a study on Thursday.
Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus, such as in the ovaries and fallopian tubes. It is more common among women between the ages of 30 and 40 and can cause severe pelvic pain, and abnormal or heavy menstrual flow.
To date, there is no cure or way to prevent endometriosis. Its symptoms can be treated with medicines.
While men are long known to be at higher risk of heart disease, the study by Danish researchers showed women with endometriosis have a 35 per cent increased risk of acute myocardial infarction (heart attack). They also had 20 per cent more chances of ischaemic stroke compared to those without endometriosis.
The study showed that the 40-year cumulative incidence of these conditions was 17.5 per cent and 15.3 per cent, respectively.
“For decades, cardiovascular disease (CVD) has been thought of as a man’s disease and risk factors have been considered from the male perspective, for example, including erectile dysfunction in guidelines on CVD risk assessment. Yet, one in three women die from CVD and one in 10 women suffer from endometriosis,” said lead author Dr. Eva Havers-Borgersen from Rigshospitalet Copenhagen University Hospital, in Denmark.
“Our results suggest that it may be time to routinely consider the risk of CVD in women with endometriosis,” she added.
The research made use of Danish registries that included women diagnosed with endometriosis between 1977 and 2021.
In the analysis, 242,032 matched controls and 60,508 endometriosis-affected women were included. The controls were followed for a maximum of 45 years, and the median follow-up period was 16 years.
The women with endometriosis were also likely to be more prone to a higher risk of arrhythmias and heart failure. The study suggests that women with endometriosis should undergo cardiovascular risk assessment and consider female-specific risk factors in cardiovascular risk prediction models.
This research will be presented at the ongoing European Cardiology Congress, London (August 30-September 2).
–IANS
ts/rvt/
ସଡ଼କ ସୁରକ୍ଷା ପଦକ୍ଷେପରେ ଓଡ଼ିଶାକୁ ଶ୍ରେଷ୍ଠ ରାଜ୍ୟ ସମ୍ମାନ
Next Articleଶ୍ରୀମନ୍ଦିରରେ କୋଳିବିକା ନୀତି ପାଳିତ
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
